Sale!

PIEZO2 Gene Arthrogryposis Distal Type 3 Genetic Test Cost

Original price was: 5,600 د.إ.Current price is: 4,400 د.إ.

-21%

The PIEZO2 Gene Arthrogryposis Distal Type 3 Genetic Test is a specialized diagnostic tool designed to detect mutations in the PIEZO2 gene, which are associated with Arthrogryposis Distal Type 3, a rare genetic disorder. This condition is characterized by congenital contractures in the distal parts of the limbs, affecting the movement and positioning of the hands and feet. The test involves analyzing the patient’s DNA to identify any genetic alterations in the PIEZO2 gene that could lead to the disorder.

Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, this test provides crucial information for families and healthcare providers. It aids in the early diagnosis, management, and understanding of the condition, allowing for better-informed decisions regarding care and treatment options. The cost of the test is set at 4400 AED, reflecting the comprehensive analysis and expertise required to accurately interpret the results. Through this testing, individuals and families gain valuable insights into the genetic underpinnings of Arthrogryposis Distal Type 3, empowering them with knowledge to tackle the challenges associated with the condition.

Home  Sample collection service available

  • 100% accuaret Test Results
  • Ranked as Most trusted Genetic DNA Lab
  • This test is not intended for medical diagnosis or treatment
Guaranteed Safe Checkout

PIEZO2 Gene Arthrogryposis distal type 3 Genetic Test

At DNA Labs UAE, we offer the PIEZO2 Gene Arthrogryposis distal type 3 Genetic Test. This test is designed to identify mutations or variations in the PIEZO2 gene that may be responsible for causing Arthrogryposis distal type 3 (DA3).

Test Details

The PIEZO2 gene is associated with a condition called Arthrogryposis distal type 3 (DA3). This genetic test, also known as Next-Generation Sequencing (NGS) genetic test, is used to identify mutations or variations in the PIEZO2 gene that may be responsible for causing DA3.

Arthrogryposis refers to a group of conditions characterized by multiple joint contractures, meaning that certain joints in the body are stiff and have limited movement. DA3 specifically affects the distal joints, which are the joints farthest from the center of the body, such as those in the hands and feet.

NGS genetic testing involves sequencing the DNA of an individual to identify specific variations or mutations in genes associated with a particular condition. In the case of DA3, this test would analyze the PIEZO2 gene to identify any variations or mutations that may be responsible for the development of the condition.

The results of this genetic test can help confirm a diagnosis of DA3 and provide information about the specific genetic variant involved. This information can be valuable for understanding the underlying cause of the condition, predicting disease progression, and guiding treatment options and management strategies.

Test Components and Price

Test Name: PIEZO2 Gene Arthrogryposis distal type 3 Genetic Test

Components: NGS Technology

Price: 4400.0 AED

Sample Condition and Report Delivery

Sample Condition: Blood or Extracted DNA or One drop Blood on FTA Card

Report Delivery: 3 to 4 Weeks

Test Type and Doctor

Test Type: Osteology Dermatology Immunology Disorders

Doctor: Dermatologist

Test Department and Pre Test Information

Test Department: Genetics

Pre Test Information: Clinical History of Patient who is going for PIEZO2 Gene Arthrogryposis, distal, type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PIEZO2 Gene Arthrogryposis, distal, type 3 NGS Genetic DNA Test gene PIEZO2.

Test Name PIEZO2 Gene Arthrogryposis distal type 3 Genetic Test
Components
Price 4400.0 AED
Sample Condition Blood or Extracted DNA or One drop Blood on FTA Card
Report Delivery 3 to 4 Weeks
Method NGS Technology
Test type Osteology Dermatology Immunology Disorders
Doctor Dermatologist
Test Department: Genetics
Pre Test Information Clinical History of Patient who is going for PIEZO2 Gene Arthrogryposis, distal, type 3 NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with PIEZO2 Gene Arthrogryposis, distal, type 3 NGS Genetic DNA Test gene PIEZO2
Test Details

The PIEZO2 gene is associated with a condition called arthrogryposis, distal, type 3 (DA3). This genetic test, also known as Next-Generation Sequencing (NGS) genetic test, is used to identify mutations or variations in the PIEZO2 gene that may be responsible for causing DA3.

Arthrogryposis refers to a group of conditions characterized by multiple joint contractures, meaning that certain joints in the body are stiff and have limited movement. DA3 specifically affects the distal joints, which are the joints farthest from the center of the body, such as those in the hands and feet.

NGS genetic testing involves sequencing the DNA of an individual to identify specific variations or mutations in genes associated with a particular condition. In the case of DA3, this test would analyze the PIEZO2 gene to identify any variations or mutations that may be responsible for the development of the condition.

The results of this genetic test can help confirm a diagnosis of DA3 and provide information about the specific genetic variant involved. This information can be valuable for understanding the underlying cause of the condition, predicting disease progression, and guiding treatment options and management strategies.